Regenerative Medical Technology (RMTG) Asset Utilization Ratio (2019 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Asset Utilization Ratio of 1.34 for Q1 2026, up 12.51% year-over-year from 1.19 in Q1 2025, and up 18.55% quarter-over-quarter from 1.13 in Q4 2025.
Regenerative Medical Technology (RMTG) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
Regenerative Medical Technology's Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 1.34 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 12.51% year-over-year to 1.34; the TTM figure through Mar 2026 stood at 1.34 (up 12.51% YoY), while the FY2025 annual figure was 1.23, changed 0.12% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 1.34, up from 1.13 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.34 in Q1 2026, with the low at 0.08 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 0.82 (2024), against an average of 0.71.
- The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio jumped 1876.56% in 2022, then retreated 2.83% in 2025.
- Regenerative Medical Technology's Asset Utilization Ratio stood at 0.19 in 2022, then soared by 314.77% to 0.78 in 2023, then jumped by 49.75% to 1.17 in 2024, then dropped by 2.83% to 1.13 in 2025, then rose by 18.55% to 1.34 in 2026.
- Business Quant data shows RMTG's Asset Utilization Ratio at 1.34 in Q1 2026, 1.13 in Q4 2025, and 1.12 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 1.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.34 |
| Dec 31, 2025 | 1.13 |
| Sep 30, 2025 | 1.12 |
| Jun 30, 2025 | 1.14 |
| Mar 31, 2025 | 1.19 |
| Dec 31, 2024 | 1.17 |
| Sep 30, 2024 | 1.02 |
| Jun 30, 2024 | 0.94 |
| Mar 31, 2024 | 0.82 |
| Dec 31, 2023 | 0.78 |
| Sep 30, 2023 | 0.43 |
| Jun 30, 2023 | 0.27 |
| Mar 31, 2023 | 0.25 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.15 |
| Jun 30, 2022 | 0.12 |
| Mar 31, 2022 | 0.08 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |